Greenspring Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
7,857
-8
-0.1% -$936 0.06% 140
2026
Q1
$946K Buy
7,865
+670
+9% +$77.4K 0.06% 133
2025
Q4
$757K Buy
+7,195
New +$675K 0.05% 141
2024
Q4
Sell
-3,501
Closed -$398K 100
2024
Q3
$398K Buy
+3,501
New +$416K 0.09% 58
2023
Q2
Sell
-3,203
Closed -$341K 104
2023
Q1
$341K Buy
3,203
+197
+7% +$21.3K 0.07% 93
2022
Q4
$334K Buy
3,006
+1
+0% +$102 0.09% 80
2022
Q3
$259K Sell
3,005
-98
-3% -$8.75K 0.08% 86
2022
Q2
$283K Buy
3,103
+2
+0.1% +$177 0.08% 83
2022
Q1
$254K Buy
3,101
+207
+7% +$16.3K 0.07% 92
2021
Q4
$222K Buy
+2,894
New +$231K 0.06% 106

Other funds holding MRK

Greenspring Advisors's MRK Position: Q2 2026 in Review

Greenspring Advisors reduced its Merck (MRK) stake by 0.1% in Q2 2026, selling an estimated $936 and leaving 7,857 shares worth $1.01M. The position accounts for 0.06% of the portfolio, ranked #140.

Greenspring Advisors first reported a position in MRK in Q4 2021 and has held it in 10 quarters since. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Greenspring Advisors held 7,857 shares of Merck worth $1.01M as of Q2 2026.
  • Greenspring Advisors sold 8 Merck shares in Q2 2026, an estimated $936.
  • Merck made up 0.06% of Greenspring Advisors's portfolio in Q2 2026, its #140 holding.
  • Greenspring Advisors first reported a position in Merck in Q4 2021 and has held it in 10 quarters since.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Greenspring Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.